Medical Complications of Crystal Methamphetamine

REFERENCES

• Albertson , T. E. , Derlet , R. W. and Van Hoozen , B. E. 1999 . Methamphetamine and the expanding complications of amphetamines. . Western J. Medicine , 170 : 214 – 219 .
   PubMedGoogle Scholar
• Bagasra , O. and Pomerantz , R. J. 1993 . Human immunodeficiency virus type 1 provirus is demonstrated in peripheral blood monocytes in vivo: A study utilizing an in situ polymerase chain reaction. . AIDS Rev Hum Retroviruses , 9 : 69 – 76 .
   Web of Science ®Google Scholar
• Baker , R. and Bowers , M. 1997 . Ritonavir and Ecstasy. . BETA Mar , : 5
   Google Scholar
• Berger , J. R. and Arendt , G. 2000 . HIV dementia: The role of the basal ganglia and dopaminergic systems. . J Psychopharmacology , 14 ( 3 ) : 214 – 221 .
   PubMed Web of Science ®Google Scholar
• Brosen , K. and Gram , L. F. 1989 . Clinical significance of the sparteine/debrisoquine oxidation polymorphism. . European J. Clinical Pharmacology , 36 : 537 – 547 .
   PubMed Web of Science ®Google Scholar
• Buchanan , J. F. and Brown , C. R. 1988 . “Designer Drugs”: A problem in clinical toxicology. . Medical Toxicology & Adverse Drug Experience , 3 : 1
   PubMedGoogle Scholar
• Gavrilin , M. A. , Mathes , L. E. and Podell , M. 2002 . Methampehtamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. . J. Neurovirology , 8 : 240 – 249 .
   PubMed Web of Science ®Google Scholar
• Grant , I. , Heaton , R. K. , Dawson , L. K. and Marcotte , T. D. 1999 . Abuse of methamphetamine and cocaine may enhance HIV associated neurotoxicity. . Archives Clinical Neuropsychology , 14 ( 1 ) : 130
   Web of Science ®Google Scholar
• Hales , G. , Roth , N. and Smith , D. 2000 . Possible fatal interaction between protease inhibitors and methamphetamine. . Antiviral Therapy , 5 : 19
   PubMed Web of Science ®Google Scholar
• Henry , J. A. and Hill , I. R. 1998 . Fatal interaction between ritonavir and MDMA. . Lancet , 352 : 1751 – 1752 .
   PubMed Web of Science ®Google Scholar
• Hong , R. , Matsuyama , E. and Nur , K. 1991 . Cardiomyopathy associated with the smoking of crystal methamphetamine. . JAMA , 265 : 1152 – 1154 .
   PubMed Web of Science ®Google Scholar
• House , R. V. , Thomas , P. T. and Bhargava , H. N. 1994 . Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. . Immunopharmacology & Immunotoxicolology , 16 : 1 – 21 .
   PubMed Web of Science ®Google Scholar
• Lopez , O. L. , Smith , G. , Meltzer , C. C. and Becker , J. T. 1999 . Dopamine systems in human immunodeficiency virus-associated dementia. . Neuropsychiatry, Neuropsychology & Behavioral Neurology , 12 ( 3 ) : 184 – 192 .
   PubMedGoogle Scholar
• Lynch , J. and House , M. A. 1992 . Cardiovascular effects of methamphetamine. . J. Cardiovascular Nursing , 6 : 12 – 18 .
   PubMedGoogle Scholar
• Melega , W. P. , Williams , A. E. , Schmitz , D. A. , DiStefano , E. W. and Cho , A. K. 1995 . Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal. . J. Pharmacology & Experimental Therapeutics , 274 : 90 – 96 .
   PubMed Web of Science ®Google Scholar
• Minagar , A. , Shapshak , P. , Fujimura , R. , Ownby , R. , Heyes , M. and Eisdorfer , C. 2002 . The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. . J Neurological Sciences , 202 ( 1–2 ) : 13 – 23 .
   PubMed Web of Science ®Google Scholar
• Nath , A. 2002 . Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. . J. Infectious Diseases , 186 ( Suppl 2 ) : S193 – 198 .
   PubMed Web of Science ®Google Scholar
• Nath , A. , Anderson , C. , Jones , M. , Maragos , W. , Booze , R. , Mactutus , C. , Bell , J. , Hauser , K. F. and Mattson , M. 2000a . Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. . J. Psychopharmacology , 14 ( 3 ) : 222 – 227 .
   PubMed Web of Science ®Google Scholar
• Nath , A. , Haughey , N. J. , Jones , M. , Anderson , C. , Bell , J. E. and Geiger , J. D. 2000b . Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine. . Annals Neurology , 47 : 186 – 194 .
   PubMed Web of Science ®Google Scholar
• Nath , A. , Hauser , K. F. , Wojna , V. , Booze , R. M. , Maragos , W. , Prendergast , M. , Cass , W. and Turchan , J. T. 2002 . Molecular basis for interactions of HIV and drugs of abuse. . J. Acquired Immune Deficiency Syndromes , 31 ( Suppl 2 ) : S62 – 69 .
   PubMed Web of Science ®Google Scholar
• Nath , A. , Maragos , W. F. , Avison , M. J. , Schmitt , F. A. and Berger , J. R. 2001 . Acceleration of HIV dementia with methamphetamine and cocaine. . J Neurovirology , 7 ( 1 ) : 66 – 71 .
   PubMed Web of Science ®Google Scholar
• Perez , J. A. Jr. , Arsura , E. L. and Strategos , S. 1999 . Methamphetamine-related stroke: Four cases. . J. Emergency Medicine , 17 : 469 – 471 .
   PubMed Web of Science ®Google Scholar
• Pritzker , D. , Kanungo , A. , Kilicarslan , T. , Tyndale , R. F. and Sellers , E. M. 2002 . Designer drugs that are potent inhibitors of CYP2D6. . J. Clinical Psychopharmacology , 22 : 330 – 332 .
   PubMed Web of Science ®Google Scholar
• Ramamoorthy , Y. , Tyndale , R. F. and Sellers , E. M. 2001 . Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates. . Pharmacogenetics , 11 : 477 – 487 .
   PubMedGoogle Scholar
• Richards , J. R. and Brofeldt , B. T. 2000 . Patterns of tooth wear associated with methamphetamine use. . J. Periodontology , 71 : 1371 – 1374 .
   PubMed Web of Science ®Google Scholar
• Richards , J. R. , Johnson , E. B. , Stark , R. W. and Derlet , R. W. 1999 . Methamphetamine abuse and rhabdomyolysis in the ED: A 5-year study. . American J. Emergency Medicine , 17 : 681 – 685 .
   PubMed Web of Science ®Google Scholar
• Sekine , Y. , Minabe , Y. , Ouchi , Y. , Takei , N. , Iyo , M. , Nakamura , K. , Suzuki , K. , Tsukada , H. , Okada , H. , Yoshikawa , E. , Futatsubashi , M. and Mori , N. 2003 . Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. . American J. Psychiatry , 160 ( 9 ) : 1699 – 1701 .
   PubMed Web of Science ®Google Scholar
• Varner , K. J. , Ogden , B. A. , Delcarpio , J. and Meleg-Smith , S. 2002 . Cardiovascular responses elicited by the “binge” administration of methamphetamine. . J. Pharmacology & Experimetnal Therapeutics , 301 : 152 – 159 .
   PubMed Web of Science ®Google Scholar
• Venker , D. 1999 . Crystal methamphetamine and the dental patient. . Iowa Dental J. , 85 : 34
   PubMedGoogle Scholar
• Volkow , N. D. , Chang , L. , Wang , G. J. , Fowler , J. S. , Franceschi , D. , Sedler , M. , Gatley , S. J. , Miller , E. , Hitzemann , R. , Ding , Y. S. and Logan , J. 2001a . Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. . J. Neurosciences , 21 : 9414 – 9418 .
   PubMed Web of Science ®Google Scholar
• Volkow , N. D. , Chang , L. , Wang , G. J. , Fowler , J. S. , Leonido-Yee , M. , Franchesi , D. , Sedler , M. J. , Gatley , S. J. , Hitzemann , R. , Ding , Y. S. , Logan , J. , Wong , C. and Miller , E. N. 2001b . Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. . American J. Psychiatry , 158 ( 3 ) : 377 – 382 .
   PubMed Web of Science ®Google Scholar
• Weland , M. 2002 . Crook's bad teeth costing taxpayers. . Kootenai County News , Jan 20
   Google Scholar
• Woolverton , W. L. , Ricaurte , G. A. , Forno , L. S. and Seiden , L. S. 1989 . Long-term effects of chronic methamphetamine administration in rhesus monkeys. . Brain Research , 486 : 73 – 78 .
   PubMed Web of Science ®Google Scholar